At 7.4% CAGR, the Europe Biosafety Cabinet Market is projected to be worth US$ 133.61 million by 2028, says The Business Market Insights   

According to the Business Market Insights’ research, the Europe biosafety cabinet market was valued at US$ 93.35 million in 2023 and is expected to reach US$ 133.61 million by 2028, registering a CAGR of 7.4% from 2023 to 2028.  Rising prevalence of infectious diseases and rising strategic initiatives are the critical factors attributed to the Europe biosafety cabinet market expansion.                            

Companies are investing in the development of new and innovative instruments to secure good return on investment (ROI). Additionally, the product approval by regulatory authorities confirms reliability and credibility of the new age control units and sanitized workstations. Recently, various market players have launched high-end and top-quality biosafety cabinets and adopted acquisition strategy in the market. A few strategies by market players have been done in recent years. For instance, in September 2022, Thermo Fisher Scientific launched the Thermo Scientific 1500 Series Biological Safety Cabinet (BSC), designed to meet the demands of most laboratories and provide protection from biological hazards and contamination. Similarly, in May 2021, Labconco launched the updated Purifier Axiom Biosafety Cabinet. The exclusive features of the Labconco Class II, Type C1 Axiom series biosafety cabinets have made them highly sought-after safety tools for almost any microbiological application. Further, in February 2021, Thermo Fisher Scientific expanded its offering of Class II Biological Safety Cabinets (BSCs) with advancement in existing products. The cabinets are designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic, and biopharmaceutical laboratories. These recent developments enhance the mode of performing experiments in large and medium-sized laboratories that work with cell cultures. The mounting number of novel product launches and acquisitions facilitates the growth of the Europe biosafety cabinet market.

On the contrary, high cost and maintenance of biosafety cabinets hurdles the growth of Europe biosafety cabinet market.

Based on products handled, the Europe biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held 79.8% share of Europe biosafety cabinet market in 2023, amassing US$ 74.53 million. It is projected to garner US$ 103.78 million by 2028 to expand at 6.8% CAGR during 2023–2028.     

Based on category, the Europe biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held 59.4% share of Europe biosafety cabinet market in 2023, amassing US$ 55.42 million. It is projected to garner US$ 81.73 million by 2028 to expand at 8.1% CAGR during 2023–2028.          

Based on type, the Europe biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held 74.9% share of Europe biosafety cabinet market in 2023, amassing US$ 69.94 million. It is projected to garner US$ 102.46 million by 2028 to expand at 7.9% CAGR during 2023–2028.       

Based on application, the Europe biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held 51.1% share of Europe biosafety cabinet market in 2023, amassing US$ 47.71 million. It is projected to garner US$ 68.94 million by 2028 to expand at 7.6% CAGR during 2023–2028.           

Based on end user, the Europe biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held 48.6% share of Europe biosafety cabinet market in 2023, amassing US$ 45.36 million. It is projected to garner US$ 66.71 million by 2028 to expand at 8.0% CAGR during 2023–2028.             

Based on country, the Europe biosafety cabinet market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.3% market share in 2023. It was assessed at US$ 27.39 million in 2023 and is likely to hit US$ 38.47 million by 2028, exhibiting a CAGR of 7.0% during the forecast period.           

Key players dominating the Europe biosafety cabinet market are ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc among others.      

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com